This compound is a fluorinated quinoline derivative featuring an azetidine ester substituent. It is primarily used as a pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
pharmaceutical intermediate
Tabersonine
pharmaceutical intermediate
Ethylboronic acid
pharmaceutical intermediate
Α-acetylbenzeneacetamide
pharmaceutical intermediate
3-Chloro-4-(3-fluorobenzyloxy)nitrobenzene
pharmaceutical intermediate
Delafloxacin
pharmaceutical raw material
Delafloxacin meglumine
pharmaceutical raw material
ethyl 1-(6-amino-3,5-difluoro-2-pyridinyl)-6-fluoro-7-[3-(2-methylpropanoyloxy)azetidin-1-yl]-4-oxoquinoline-3-carboxylate
VMXLACIKUJJQTC-UHFFFAOYSA-N
CCOC(=O)C1=CN(C2=CC(=C(C=C2C1=O)F)N3CC(C3)OC(=O)C(C)C)C4=C(C=C(C(=N4)N)F)F
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.